NCT06993168

To Evaluate Effect of Food of DA-5222 in Healthy Adult Subjects

An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Crossover Phase 1 Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of DA-5222 in Healthy Adult Subjects

• Status: Not Yet Recruiting
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 32 (estimated)
• Sponsor: Dong-A ST Co., Ltd. · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

This study is to evaluate the effect of food on pharmacokinetics of DA-5222 in healthy adult subjects

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	DA-5222	single dose administration (DA-5222 one tablet once a day)

Timeline

• Start date: 2025-05-21
• Primary completion: 2025-07-01
• Completion: 2025-07-01
• First posted: 2025-05-28
• Last updated: 2025-05-28

Locations

1 site across 1 country: South Korea